TPST vs ULTA · $26.3M cap vs P/E 17, rev $6.20B
Tempest Therapeutics Inc (TPST) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
TPST does not have a complete income-statement cache yet.
Latest reported ULTA revenue for 2026-08-01 was $6.20B. Net income was $622.5M. Revenue was up 95.9% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
TPST currently screens at market cap $26.3M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the TPST and ULTA stock pages for the full models.
Not investment advice.